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Mycobacterium kansasii is an important opportunistic pathogen of humans and has a
close phylogenetic relationship with Mycobacterium tuberculosis. Seven subtypes (I–VII)
have been identified using molecular biology approaches, of which subtype I is the
most frequent causative agent of human disease. To investigate the genotypes and
pathogenic components of M. kansasii, we sequenced and compared the complete
base-perfect genomes of different M. kansasii subtypes. Our findings support the
proposition that M. kansasii “subtypes” I-VI, whose assemblies are currently available,
should be considered as different species. Furthermore, we identified the exclusive
presence of the espACD operon inM. kansasii subtype I, and we confirmed its role in the
pathogenicity of M. kansasii in a cell infection model. The espACD operon is exclusively
present in mycobacterial species that induce phagosomal rupture in host phagocytes
and is known to be a major determinant of ESX1-mediated virulence in pathogenic
mycobacteria. Comparative transcriptome analysis of theM. kansasii I-V strains identified
genes potentially associated with virulence. Using a comparative genomics approach,
we designed primers for PCR genotyping of M. kansasii subtypes I-V and tested their
efficacy using clinically relevant strains of M. kansasii.
Keywords: non-tuberculous mycobacteria, comparative genomics, M. kansasii subtypes, espACD operon,
virulence factor
INTRODUCTION
Nontuberculous mycobacteria (NTM) are increasingly being recognized as important
opportunistic pathogens of humans. Reports have shown that more than 50 species of mycobacteria
are associated with human diseases (Griffith et al., 2007), and Mycobacterium kansasii is the one
of the most common causes of NTM disease in South America, South Africa and Europe
(Hoefsloot et al., 2013).
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M. kansasii was named after it was isolated from two
patients suspected of having tuberculosis in Kansas, USA; it
was previously known as the “yellow bacillus” (Pollak, 1953).
This raised attention because it is difficult to treat patients co-
infected with human immunodeficiency virus (HIV) (Levine and
Chaisson, 1991; Corbett et al., 1999). In addition to systemic
infection,M. kansasii also causes lung, cervical lymph node, and
skin infections (Breathnach et al., 1995). Seven major subtypes
have been described based on PCR-restriction fragment length
polymorphism (RFLP) of hsp65 and internal transcribed spacer
(ITS) (Taillard et al., 2003), while subtype I remains the most
commonly isolated from clinical environments (Taillard et al.,
2003; Borówka et al., 2017; Machado et al., 2018). A recent
study proposed that the “subspecies” of M. kansasii should be
considered as new species (Tagini et al., 2019).
Previous phylogenetic studies have suggested that
Mycobacterium marinum (Stinear et al., 2008), Mycobacterium
lacus (Tortoli et al., 2017), Mycobacterium decipiens (Brown-
Elliott et al., 2018), Mycobacterium shinjukuense (Saito et al.,
2011), Mycobacterium. riyadhense (Fedrizzi et al., 2017;
Guan et al., 2019; Sapriel and Brosch, 2019) along with
M. kansasii are closely related to the free-living ancestor of the
Mycobacterium tuberculosis complex (MTBC). Phylogenetically,
M. kansasii is closely related to M. tuberculosis (Wang et al.,
2015), and the clinical manifestation of M. kansasii infections
also shows significant overlap with the clinical profile of
M. tuberculosis infections. M. kansasii has been suggested
to represent the environmental ancestor of M. tuberculosis
and can serve as a potential model organism to study
evolutionary aspects of the switch from an opportunistic
environmental pathogen to a professional host-restricted
pathogen (Wang et al., 2015).
The pathogenesis of mycobacteria depends on the secretion
of key virulence factors by the ESX-1 secretion system,
which is absent in the vaccine strain Mycobacterium bovis
BCG (Mahairas et al., 1996; Pym et al., 2002; Hsu et al.,
2003). Substrates of this secretion system are responsible for
phagosomal escape of pathogenic mycobacteria in macrophages
and thereby for successful completion of the intracellular
infection cycle (van der Wel et al., 2007). The espACD operon
(Rv3616c∼Rv3614c, espA, espC, and espD), a group of non-
RD1 loci (Fortune et al., 2005; MacGurn et al., 2005), is
essential for ESX-1 function, and its presence in the NTM
pathogen M. kansasii subtype I is of particular interest in
this study.
To explore the complexity of M. kansasii subtypes and
understand why M. kansasii subtype I is most commonly
associated with human diseases, we generated high-quality
genomes of all five available subtypes of M. kansasii using a
combination of Illumina and Pacific Biosciences sequencing
technologies. Furthermore, we undertook a comprehensive
comparative genomics and transcriptomics approach to identify
components of potential M. kansasii subtype I virulence factors,
as well as establish the role of the espACD operon in the
pathogenicity of M. kansasii. By utilizing genome sequences, we
also designed PCR-based genotyping primers for distinguishing
M. kansasii subtypes.
METHODS AND MATERIALS
Ethics Statement
The research protocol was approved by the Institutional Biosafety
and Bioethics Committee of King Abdullah University of Science
and Technology (Jeddah, Saudi Arabia; #18IBEC23).We confirm
that all adult subjects provided informed consent, and a parent of
the child participant provided informed consent on his behalf.
Written informed consent was given.
Bacterial Strains and Cell Culture
Conditions
We collected five environmental M. kansasii strains, designated
KAUST-I to KAUST-V, that were originally isolated from either
water or soil samples from five different European countries.
Sixteen gDNA samples isolated from clinically relevant strains
were also included in the study. These strains were collected from
Radboud UMC Center of Infectious Diseases in the Netherlands.
The isolates we collected were subtyped using the hsp65 gene
as discussed before (Telenti et al., 1993) and subtype I-V were
found, which are mostly isolated in many clinical cases (Taillard
et al., 2003; Houben et al., 2012; Borówka et al., 2017; Machado
et al., 2018) and no subtype VI and VII was detected.
M. kansasii subtypes I-V (strains KAUST-I to KAUST-V) were
grown in Middlebrook 7H9 (Saitoh et al., 2000) broth with
0.5% glycerol, 0.05% polysorbate 80 and OADC (0.85% sodium
chloride, 5% bovine albumin, 2% dextrose, 0.003% catalase)
at 37◦C. The human monocytic cell line THP-1 (ATCC R©
TIB-202TM) was grown in Roswell Park Memorial Institute
medium (RPMI)-1640 supplemented with 10% fetal bovine
serum, 100µg/mL penicillin and 100µg/mL streptomycin at
37Â◦C with 5% CO2.
DNA Isolation, Library Preparation,
Assembly, and Genome Annotation
M. kansasii subtypes I-V DNA were isolated using a phenol-
chloroform extraction protocol (Belisle and Sonnenberg, 1998).
The extracted genomic DNA molecules were then sequenced
using PacBio RSII sequencer with a 10 kb SMRT library. In
parallel, genomic DNAs from M. kansasii subtypes I-V were
sheared into ∼500 bp fragments using CovarisTM. Paired-end,
Illumina TruSeq PCR-FreeTM libraries were generated following
the manufacturer’s instruction, and the libraries were sequenced
on a HiSeq2000 platform. The genomes were assembled into
contigs using Canu (Koren et al., 2017) and corrected using
Pilon (Walker et al., 2014) with PCR-free Illumina reads, and the
complete assemblies were annotated by Prokka (Seemann, 2014).
Genotyping and Comparative Genomics of
M. kansasii
To gain a better understanding of the M. kansasii pan-genome
and develop a quick and accurate genotyping protocol, we
downloaded fortyM. kansasii genome sequences available on the
NCBI genome database before Oct. 15th, 2018. We compared
the phylogeny of these strains based on the hsp65 gene and
ITS using the RaxML maximum-likelihood method (Stamatakis,
2014) with 100,000 replicates. Given that the standard method
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for reconstructing phylogenies of closely related microbes is
the core-genome single-nucleotide polymorphism sites (SNPs)
typing method, we also called the SNPs from the downloaded
strain assemblies using Parsnp from the Harvest suite (Treangen
et al., 2014) and generated the phylogenomic relationship map
of M. kansasii. The phylogenetic tree was generated based on
135,969 core SNPs from each of the assemblies using the RaxML
maximum-likelihood method (Stamatakis, 2014) with 100,000
replicates. In addition, the average nucleotide identity (ANI)
between every two assemblies was calculated by OrthoANI
(Lee et al., 2016). To determine the paralogous gene groups of
the M. kansasii subspecies, the predicted protein sequences of
M. kansasii subtypes I–V andM. tuberculosiswere analyzed using
OrthoMCL (Li et al., 2003) with a 50% identity cut-off and an
inflation parameter of 1.5. The ortholog groups were visualized
as a Venn diagram with the R VennDiagram package (Chen
and Boutros, 2011). Mauve (Darling et al., 2004) was used to
align the genomes of the subtypes to reveal the structure of the
backbones of the chromosomes. The whole-genome comparison
against subtype I was analyzed and visualized with BLAST Ring
Image Generator (BRIG) (Alikhan et al., 2011). The uniqueness
of singletons from each subtype and unique ortholog groups was
further examined by BlastN (Version 2.2.26) against each other
with 60% identity and an E-value of 0.00001 as the cutoff. The
functional annotation of these genes was analyzed by EggNOG
(Huerta-Cepas et al., 2016).
Investigation of the Role of the espACD
Operon in M. kansasii Pathogenicity
During our comparative genome analysis of the M. kansasii
subtypes and the list of genes that are uniquely present in the
subtype I, we have observed the presence of an espACD operon,
which is known to have an important role in ESX-1 secretion
(Ates and Brosch, 2017). To investigate the functional role of
the espACD operon in M. kansasii subtype I, we constructed
the pSMT3-espACD-GFP plasmid, and it was transformed into
M. kansasii subtype II using the electroporation method (Goude
et al., 2015) to investigate the function of the espACD operon.
The espACD operon of M. kansasii subtype I was amplified
with the primers EspACD-HindIII (TTTTAAGCTTCGGG
ACTTGCGCTTAGTCTG) and EspACD- AflII (TTTTCTTAA
GGTGGCCGCCCGTTTATGTAG). The DNA fragments were
digested with HindIII and AflII and cloned into an AflII-
restriction site containing a variant of pSMT3 digested with
the same enzymes. The resulting plasmid, pSMT3-espACD-
GFP, is a shuttle plasmid that is difficult to incorporate
directly into M. kansasii. Therefore, we introduced the OriT
region of pRAW (Ummels et al., 2014) and introduced
the plasmid into Mycobacterium marinum. Subsequently, we
introduced the plasmid pSMT3-espACD-GFP into M. kansasii
through conjugation.
Cultures of the different subtypes of M. kansasii (wild-
type subtype I, wild-type subtype II, subtype II transferred
with pSMT3-espACD-GFP, and subtype II transferred with
pSMT3-GFP) with an OD600nm = 0.8–1.0 were prepared.
Simultaneously, THP-1 cells (Tsuchiya et al., 1980) were
counted using a haemocytometer and diluted to seed half a
million cells per well in 24-well plates in the presence of
25 ng/mL phorbol myristate acetate (PMA) to allow the cells
to differentiate into macrophages and adhere overnight at
37◦C with 5% CO2. After their differentiation, the complete
medium was replaced with RPMI+10% FCS without antibiotics
and incubated for 3 h. The macrophages were incubated
in triplicate with M. kansasii KAUST-I, KAUST-II, KAUST-
II-pSMT3-espACD-GFP, and KAUST-II-pSMT3-GFP, with a
multiplicity of infection (MOI) = 5, or incubated with only
medium. After 2 h of infection, the macrophages were washed
with PBS and incubated with fresh medium without antibiotics.
The cells were then treated with 1mL of 1% Triton X-100
for 10min at 37◦C and collected at different time points
after infection (0, 24, 48, and 72 h). Then, the obtained
lysates were diluted to 1:10, 1:100, and 1:1,000, and 100 µL
of each dilution was subsequently spread on Middlebrook
7H10 agar plates. The survival rate was evaluated as the
percentage of colony forming units (CFUs) at different time
points, taking the number of CFUs at time point “0” as
the reference.
Development of Genotyping Primers for
M. kansasii Subtypes
The unique genes within each singleton pool were further
investigated. We used BlastN against the non-redundant (nr)
nucleotide database for the unique genes and refined the list of
selected unique genes after comparison against the other species
in the nr database. The unique genes were also confirmed by the
binary alignment map (BAM) files generated by cross-mapping
of Illumina reads to each subtype. The primer sets that target the
unique genes are presented in Table 1. Primer sets that target
the 16S rRNA V2∼V4 regions were used as internal controls.
GoTaqTM Green Master Mix was used for the amplification, and
the cycling conditions for these primers consisted of preheating
at 95◦C for 2min, followed by 30 cycles of denaturation at 95◦C
for 30 s, annealing at 62◦C for 30 s and extension at 72◦C for
30 s. The final extension was performed at 72◦C for 10min after
30 cycles.
Transcriptome Analysis of M. kansasii
Subspecies
Total RNAwas extracted from 40ml of exponential growth phase
culture bacterial culture using the TRIzol protocol (Rio et al.,
2010). Briefly, the bacterial cultures were centrifuged at 1,500
rcf for 15min, suspended in 1mL of TRIzol and incubated for
5min. Then, 500 µL of zirconia beads (BiospecTM) were added
and treated six times by beating at maximum speed for 30 s.
Then, the mixture was centrifuged, and the upper layer was
incubated with 200µL of chloroform. After centrifugation at 4◦C
at maximum speed for 20min, an equal volume of isopropanol
was added to the aqueous layer. The mixture was centrifuged
at 4◦C at full speed, and the supernatant was discarded. Then,
1.5mL of 70% cold ethanol was added and centrifuged for
10min. The ethanol was discarded, and the RNA was air-dried.
The RNA was suspended in 30 µl of RNase-free water and
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TABLE 1 | Primer sets designed from selected sequences of M. kansasii subtypes I-V.
Primer ID Target gene Amplicon Length (bp) Forward Primer (5′-3′) Reverse Primer (5′-3′)
DPT1a kaust1_03087 199 GTTCGTCTCGATTTCGCAGC GAATCACGCGCCTTGATGAC
DPT2 kaust2_05863 312 TTTCGGACAATGACGGCGGACG ATGCAGTGTCCGGCAAAGGGGT
DPT3 kaust3_04009 250 TGGCGGGTGTGTTGATGATGGC ATCAGCGGCAACGGCGGTAA
DPT4 kaust4_00078 111 GATGGTCAAATCGAGCGACGAGGCG GCGACGGGTTCATCGGCAGTGATT
DPT5 kaust5_02691 445 ACGCCTTGGAACGTGACCGTGA ACTGATTCGTGGCCCGGATGGA
Internal control kaust1_00615, kaust2_00230, kaust3_03982,
kaust4_05573, kaust5_02753b
591 TGGCGCATGCCTTGTGGTGGAA TCCTGTTCGCTCCCCACGCTTT
aDiagnostic primer for subtype I.
b Internal control that targets the 16S rRNA gene.
incubated at 60◦C until all of the RNA was dissolved. The
RNA was then stored at −80◦C before library preparation. For
library preparation, DNA was removed using TurboTM DNase,
and rRNA was removed using the InvitrogenTM Ribominus
Kit. Strand-specific Illumina RNAseq libraries were prepared
using the TruSeq kit following the manufacturer’s manual,
and the libraries were sequenced on a HiSeq2000 platform
(IlluminaTM). The RNAseq reads obtained were first trimmed
using the Trimomatic program (Bolger et al., 2014) to remove
adapters and low-quality reads (cutoff: Q30). The “clean reads”
were further mapped to the annotated genomes of M. kansasii
subtypes I-V. To compare the differences between M. kansasii
subtype I and the four other subtypes, the transcriptomes of
the 3,761 one-to-one orthologs obtained from OrthoMCL were
compared. The RNAseq reads were mapped to each genome
with HISAT2 (Pertea et al., 2016), and the reads mapped to each
gene were counted by HTSeq (Anders et al., 2015) with union
mode. DESeq2 (Anders and Huber, 2013) was used to call the
differentially expressed genes. Genes with a padj value < 0.01
and an absolute Log2 fold change value greater than two were
selected and further analyzed. The same method was applied to
determine the differentially expressed genes (DEGs) in the other
fourM. kansasii subtypes.
RESULTS
Comparative Genomics of M. kansasii
Subtypes I–V
To study the variation in the M. kansasii subtypes, we obtained
isolates belonging to each subtype and used a combination
of Illumina and SMRT (PacBio) sequencing methods to
assemble genomes into single base-perfect contigs. All of
the bacterial chromosomes of M. kansasii subtypes I-V were
assembled into a single contig each, and the genome of
M. kansasii subtype III included a large new 301,558 bp
circular plasmid pMKIII01 (Supplementary Figure 1) that has
not been described before. The sequencing depths of each of
the assemblies (subtype I–V) from PacBio were 251X, 122X,
98X, 148X, and 158X, respectively. The comparison of these
genome assemblies with M. tuberculosis H37Rv, M. marinum
M and the type strain M. kansasii 12478 are shown in
Table 2. The comparison of our assemblies with previously
published genomes from the same strains is described in
Supplementary Table 1. The backbone structure of subtypes
I–V is shown in Supplementary Figure 2, and the BlastN
comparison of subtypes II–V to subtype I is shown in
Figure 1.
The ortholog groups cluster across the genomes of the
different M. kansasii subtypes, and the functional annotation
categories of the paralogues/singletons are presented in
Figure 2A. The number of unique singletons of each subtype
that did not appear in the Venn diagram from M. kansasii
subtypes I-V was 555, 628, 608, 756, and 642, respectively,
most of which were proteins with unknown functions. This
means that all subtypes have a similar number of singletons,
indicating that they have similar genetic headroom and
evolutionary pressures. The comparison of M. kansasii
subtypes and M. tuberculosis H37Rv is shown in Figure 2B.
A detailed analysis of the genes shared between M. kansasii
subtype I and M. tuberculosis H37Rv is presented in
Supplementary Table 2.
One of the striking findings in the comparative
genomic analysis was that one copy of the espACD operon
(kaust1_3087∼kaust1_3085) is present exclusively in subtype
I (Figure 1, Supplementary Figure 3). We examined
whether these espACD loci are involved in the virulence
ofM. kansasii.
Genotyping of M. kansasii
Various molecular methods for genotyping M. kansasii have
been developed for comparison and strain identification (Zhang
et al., 2004). To study the subtypes in detail, we analyzed
the available 45 sequenced M. kansasii genome datasets. The
analysis revealed that the phylogenetic tree that was constructed
based on the ITS sequences grouped the M. kansasii subtypes
incorrectly in some cases (Figure 3) due to limited information
provided in the sequences (Supplementary Figure 4). In silico
genotyping of the subtypes of the 45 M. kansasii strains based
on whole-genome core SNPs and ANI revealed that there are
six major subtypes of M. kansasii that have been sequenced in
full length so far (Figure 3, Supplementary Table 3). The ANI
value between the subtypes ofM. kansasii is high, which supports
the idea that M. kansasii “subtypes” I-VI should be considered
as different species; e.g., the ANI value between subtype VI and
subtype III is 89.35–89.48, and the value between subtype II
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TABLE 2 | Comparison of general features/gene families of M. kansasii subtypes I-V with those of other Mycobacteria.
Features M. kansasii
ATCC12478
M. kansasii
KAUST-I
M. kansasii
(Mycobacterium
pseudokansasii)
KAUST-II
M. kansasii
(Mycobacterium
parakansasii)
KAUST-III
M. kansasii
(Mycobacterium
probekansasii)
KAUST-IV
M. kansasii
(Mycobacterium
novokansasii)
KAUST-V
M.
tuberculosis
H37Rv
M. marinum E11
Genome Size
(M)
Chromosome:6.43
Plasmid
pMK12478:0.14
6.52 6.40 Chromosome:6.39
pMKIII01: 0.30
6.24 6.09 4.41 Chromosome:6.34
pRAW:0.11
GC content
(%)
Chromosome:66.2
Plasmid
pMK12478:
65.8
66.20 66.13 Chromosome:66.22
pMKIII01:64.48
66.20 66.36 65.6 Chromosome:65.8
pRAW: 64.1
CDS Chromosome:
5,631
Plasmid
pMK12478:152
5209 5211 Chromosome:5223
pMKIII:344
5145 5009 3,906 Chromosome:
5,149
pRAW:94
tRNA Chromosome:
46
Plasmid: NA
55 56 Chromosome:52
pMKIII01:NA
50 54 45 Chromosome: 47
pRAW:NA
rRNA Chromosome:
3
Plasmid: NA
3 3 Chromosome:3
pMKIII01:NA
3 3 3 Chromosome: 3
pRAW: NA
Reference Cole et al.,
1998
This study This study This study This study This study Wang et al.,
2015
Weerdenburg
et al., 2015
and subtype VI is 92.86–92.95. Therefore, we conclude that M.
kansasii subtypes I-VI should be assigned as different species.
This finding is in line with a recently published result describing
the ANI values betweenM. kansasii subtypes (Tagini et al., 2019)
in which the authors proposed that M. kansasii subtypes III,
V and VI should be considered as independent species rather
than subspecies.
Comparative Transcriptome Analysis
To reveal the differences in expression profiles of M. kansasii
subtypes, we performed a global transcriptome analysis across
M. kansasii subtypes I-V grown in vitro, focusing on the
changes in gene expression profiles during the exponential
growth of the bacilli in Middlebrook 7H9 medium. To
investigate this, RNA was extracted from three independent
exponential phase cultures of M. kansasii subtypes I-V.
Data quality was assessed using Euclidean distance matrices
and demonstrated high levels of reproducibility between
the biological replicates (Supplementary Figure 5). After
filtering, a total of 38 genes were uniquely downregulated
and 10 genes were upregulated in M. kansasii subtype I in
comparison with M. kansasii subtypes II-V within the one-to-
one ortholog groups (Figure 4A) (Supplementary Table 4).
Analysis of differential expression in M. kansasii subtype
I identified changes in genes involved in a variety of
cellular processes, mostly genes associated with metabolic,
respiratory, regulatory and cell wall-associated processes
(Figure 4B).
We noted that a substantial number of genes that are
likely essential and required for mycobacterial growth (Sassetti
et al., 2003; Weerdenburg et al., 2015) were differentially
regulated in M. kansasii subtype I, including genes involved
in cell wall-associated processes (mpt63) and lipid metabolism
(accD4, mbtC) (Supplementary Table 4). In addition, many of
these differentially regulated genes encode proteins of unknown
function and hence need to be further characterized (Figure 4A).
However, we did not notice any well-known virulence genes in
the list.
To determine the functional classifications and pathways
of the DEGs associated with each subtype, all upregulated
DEGs from each subtype were analyzed with EggNOG Mapper
(Huerta-Cepas et al., 2016) (Supplementary Table 5). The
different KEGG pathways associated with the DEGs were as
follows: three pathways for M. kansasii subtype I, twenty-one
pathways for M. kansasii subtype II, nine pathways for M.
kansasii subtype IV and 14 pathways for M. kansasii subtype
V. Notably, metabolic pathways were significantly dominant in
all subtypes.
Complementation of the espACD Operon
Recovers the Pathogenicity of the
Non-pathogenic M. kansasii Subtype II
M. kansasii subtype I contains five ESX systems, and the
overall arrangement of the five ESX systems is similar to
that in M. tuberculosis H37Rv (Supplementary Figure 6). This
includes the ESX-1 region, which is important for virulence
in M. tuberculosis (Conrad et al., 2017; Tiwari et al., 2019).
Previous research has shown that the ESX-1 substrate EsxA
is secreted by both M. kansasii subtype I and subtype V
(Houben et al., 2012). Surprisingly, the same study also showed
using electron microscopy that only M. kansasii subtype I
is able to escape from the phagolysosome (Houben et al.,
2012).
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FIGURE 1 | Circular map representation of the M. kansasii subtype II–subtype V genome showing BlastN similarities to M. kansasii subtype I. Each ring of the circle
corresponds to a specific complete genome as referred to in the figure keys on the right. The espACD operon position in M. kansasii KAUST I is indicated by an arrow.
To test whether this espACD locus could affect the virulence
of M. kansasii, we cloned the espACD gene cluster of subtype I
on a shuttle plasmid and introduced this plasmid into subtype
II, which does not have the espACD operon. We first confirmed
that there are no in vitro growth differences among the tested
strains (Supplementary Figure 7). Subsequently, differentiated
THP-1 monocytes were infected with these strains. After 3 days,
we observed a significant decrease in the survival rate of wild-type
M. kansasii subtype II and the same bacterial strain harboring
the control plasmid pSMT3-GFP (Figure 5). On the other hand,
wild-type subtype I and the subtype II strain transfected with
pSMT3-espACD-GFP had significantly increased CFU numbers.
We concluded that the presence of the espACD operon was able
to increase the virulence ofM. kansasii subtype II (Figure 5).
M. kansasii Subspecies Genotyping
Many genotypingmethods have been applied for the subtyping of
M. kansasii. Several of those methods either failed to distinguish
all of the subtypes, such as AccuProbeTM (Tortoli et al., 1996) and
INNO LiPATM (Suffys et al., 2001), or involved sequencing (Park
et al., 2000) or restriction enzyme digestion (Bakuła et al., 2013)
steps. To simplify the genotyping method for these different
subtypes, especially the more virulent subtype I, we developed a
genotyping method that can rapidly and accurately distinguish
M. kansasii subtypes I-V by PCR (Figures 6A–E). The primer
sets accurately identify M. kansasii subtypes and can serve as
part of an accurate and rapid diagnostic protocol in a clinical
setting (Figure 6F) to overcome misdiagnosis or extensive lab
work using the hsp65 and ITS regions (Figure 3).
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FIGURE 2 | Comparative genomics study of the chromosomes of M. kansasii subtypes I to V. Venn Diagram of the ortholog groups and paralogue groups shared by
(A) the five M. kansasii subtypes and (B) the five subtypes with M. tuberculosis H37Rv. The number represents the ortholog groups or paralogue groups present in
the particular types.
DISCUSSION
We obtained high-quality genomes of the five most frequently
observed types of M. kansasii by applying a combination
of short reads and long reads from the Illumina and
PacBio platforms, respectively. This allowed us to undertake
a comprehensive genome comparison at single base-pair
resolution and define the key hallmarks of the five subtypes of
sequencedM. kansasii strains.
As expected, owing to the environmental niche of this
bacteria, M. kansasii subtypes I-V share a large number of
orthologs that are not present in M. tuberculosis H37Rv (1148).
Toxin/antitoxin (T/A) systems were previously only reported in
M. tuberculosis while recent studies shows the expansion of the
T/A systems from NTMs to MTBC (Guan et al., 2019; Sapriel
and Brosch, 2019). The comparison of the M. kansasii subtype
I and M. tuberculosis H37Rv genomes reveal that they share
12 genes that are not present in other subspecies (Figure 2B,
Supplementary Table 2). Two copies of the toxin and antitoxin
proteins VapB12 and VapC4, which are known to be involved
in the adaptation of M. tuberculosis (Sala et al., 2014), two
mobile genetic elements genes within the RD3 ofM. tuberculosis
H37Rv (rv1584c, rv1585c) and one copy of a regulatory protein
(rv1129c) that has been shown to be required for M. tuberculosis
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FIGURE 3 | Genotyping of M. kansasii using ITS and SNPs from the complete genome assemblies. The maximum-likelihood tree based on the internal transcribed
spacer (ITS) sequences of 45 M. kansasii strains is shown on the right. The maximum-likelihood phylogenetic tree based on 135,969 SNPs from the core genome of
M. kansasii subtypes is shown on the left. Bootstrap support values are indicated on the branch as a percentage of 100,000 replicates. The branch length is ignored
for illustration purposes and displayed on each branch. The color code for each genotype: red: M. kansasii subtype I; purple: M. kansasii subtype II; yellow:
M. kansasii subtype III; green: M. kansasii subtype IV; blue: M. kansasii subtype V; brown: M. kansasii subtype VI. The strains within M. kansasii subtype I are
separated with black rectangles in the figure. The circles indicate the difference between the ITS and SNP genotyping method, and colors represent the genotypes
suggested by ANI clustering.
FIGURE 4 | (A) Gene expression profiles (log2 fold change) of the differentially expressed genes of M. kansasii subtypes II-V in comparison to M. kansasii subtype I.
The red color represents upregulated genes, and the green color represents downregulated genes compared with the control strain. padj < 0.01 and Log2FC > 2
were used as the cutoff for the selection of the genes. (B) Pie-chart showing a subdivision of all differentially expressed genes based on functional categories.
growth on cholesterol (Griffin et al., 2011) are uniquely present
in M. kansasii subtype I and M. tuberculosis H37Rv. We also
found two PPE family genes (rv1801, rv1802) that are present
in subtype I, which was reported to be essential for endothelial-
cell invasion and/or intracellular survival (Talaat et al., 2004; Jain
et al., 2006).M. kansasii phylogenetically and clinically resembles
M. tuberculosis (Wang et al., 2015), and the preservation of these
genes during the reduction of the Mycobacterium tuberculosis
complex (MTBC) genomes indicates that they may be important
for virulence and pathogenicity.
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FIGURE 5 | Complementation of the espACD operon in M. kansasii subtype II with that from M. kansasii subtype I is crucial for its virulence. The functional
complementation experiment revealed that the espACD operon plays a significant role in M. kansasii subtype II pathogenicity, at least in THP-1 cells. Intracellular CFU
count showing the bacterial load in THP-1 macrophages infected with KAUST-I (•), KAUST-II (•), KAUST-II-pSMT3 (N) and KAUST-II-pSMT3-espACD (H) at a MOI of
5. The infected macrophages were lysed at 0, 24, 48, and 72 h time-points post-infection and three dilutions of the released mycobacterial cells were plated on 7H10
agar plates. CFU were counted and recorded after 15 days of plating. Experiments were performed with three replicates, and Student’s t-test for significance was
calculated with the level of significance shown (***highly significant difference, p < 0.01).
pMKIII01 is a novel plasmid with a lower GC content
(64.48%) than the M. kansasii subtype III chromosome,
whose G+C content is 66.22%. This may suggest that this
plasmid was not originally from M. kansasii subtype III
and has been transformed into the bacterial cells during
the evolutionary processes. The new plasmid pMKIII01
(Supplementary Figure 1) harbors a locus encoding a putative
Type IV secretion system and a putative Type VII secretion
system. This plasmid resembles the conjugative mycobacterial
plasmids that have been discovered previously, such as the
type-plasmid pRAW in M. marinum (Ummels et al., 2014),
pMAH135 (Uchiya et al., 2015), and pMA100 (da Silva
Rabello et al., 2012) of Mycobacterium avium, pMyong1 from
Mycobacterium yongonense (Kim et al., 2013), pMK12478
(Veyrier et al., 2009) from M. kansasii 12478 and several
plasmids from Mycobacterium chimera (van Ingen et al.,
2017). The presence of a pRAW-like plasmid in M. kansasii
subtype III confirms that these plasmids are widespread in
the Mycobacterium genus, which seems to be logical, as they
were shown to be conjugative (Ummels et al., 2014). The
variation in the sizes of pRAW-like plasmids is significant, with
a value of 301,558 bp; the pMKIII01 plasmid is 2.5 times the
size of pRAW. Thus far, there is no evidence that pRAW-like
plasmids are directly involved in virulence, but they have been
instrumental in the evolution and duplication of the ESX systems
(Dumas et al., 2016; Newton-Foot et al., 2016).
The commonly used method for diagnosis, which is
based on the variation of hsp65 and ITS sequences, either
requires restriction enzyme digestion steps or cannot
distinguish the M. kansasii subtypes accurately (Figure 3,
Supplementary Figure 4). While the chromosomes of all five
subtypes (I-V) are syntenic and contain primarily shared
orthologs (Figure 1, Supplementary Figure 2) with a limited
number of uniquely shared patterns of genes across all of
them, the phylogenomic analyses (Figure 3) and the ANI
figures revealed unusually high levels of nucleotide diversity
amongst theM. kansasii complex (Supplementary Table 3). The
complexity of M. kansasii is greater than we previously thought,
and M. kansasii is too diverse to be considered as a single
“species” (Figure 3) given that approximately >95–96% ANI
values are considered to set the species boundary (Richter and
Rosselló-Móra, 2009). This proposition is also consistent with
the differences in virulence characteristics amongst the subtypes.
Hence, we propose to consider M. kansasii “subspecies” as
six different species: Mycobacterium pseudokansasii (previously
classified as Mycobacterium kansasii subtype II); Mycobacterium
parakansasii (previously classified as Mycobacterium kansasii
subtype III); Mycobacterium probekansasii (previously classified
as Mycobacterium kansasii subtype IV); Mycobacterium
novokansasii (previously classified as Mycobacterium kansasii
subtype V); and Mycobacterium eurokansasii (previously
classified asMycobacterium kansasii subtype VI).
In line with this, the function of M. kansasii subtype I
DEGs is diverse and includes aminopeptidase, ADP-ribose
pyrophosphatase and phenyloxazoline synthase (Figure 4A,
Supplementary Table 4), suggesting the diverse metabolic
capacities ofM. kansasii subtypes I and II–V.
There are now approximately one dozen ESX-1 substrates
identified (Champion et al., 2014; Phan et al., 2018; Sala et al.,
2018; Abdallah et al., 2019) in M. tuberculosis, and most of the
genes coding for these ESX-1 substrates are located within the
ESX-1 locus. Although ESX-1-secreted substrates are essential
for virulence, their separate roles are not well defined. This is
because the secretion of some of these substrates, such as EspA
and EsxA (ESAT-6), is mutually dependent (Fortune et al., 2005;
Houben et al., 2012). The genes located within the espACD
operon (rv3614∼rv3616c) are outside the ESX-1 loci. They
are homologous to rv3864∼rv3867, located within the ESX-1
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FIGURE 6 | Agarose gel (2%) electrophoresis of diagnostic PCR tests for M. kansasii subtypes I-V. Lane M: DNA markers. The gDNA used for testing is labeled on the
top, and the size of the ladder is labeled on the left side of each gel picture. The genotyping results for M. kansasii subtypes I-V are listed in (A–E). The clinical samples
tested with the cocktail of primers DP1-5 is shown in (F). The 16S primer control is shown in the red box. NTC, Non-template control.
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locus and required for ESX-1 secretion for virulence (MacGurn
et al., 2005). While no evidences that suggest there are any
connections of these two groups of genes. Comparative genome
analyses suggest that the espACD serves as a pathogenetic island
(Simeone et al., 2012; Majlessi et al., 2015) which might be
introduced independently by horizontal transfer from different
species (Ates and Brosch, 2017). EspC associates with EspA
in the cytoplasm and membrane, then polymerizes during
secretion from M. tuberculosisis. EspC forms a filamentous
structure in the cell envelope of M. tuberculosis hence affects
ESX-1 secretion (Lou et al., 2017). We have confirmed that
the espACD operon plays a crucial role in the pathogenicity
of M. kansasii. Functional complementation of the espACD
operon in wild-type M. kansasii subtype II was able to recover
the persistence phenotype (Figure 5). It is probable that this
increased persistence is induced by complementation of the ESX
secretion system, which might be essential for bacteria survival
within macrophages. Not surprisingly, M. kansasii subtype II-
pSMT3-espACD-GFP was still less virulent than the wild-type
M. kansasii subtype I because the espACD operon is under
the control of EspR (Raghavan et al., 2008; Kumar et al.,
2016) and PhoPR (Frigui et al., 2008), which are missing in
the plasmid.
In conclusion, our study reveals thatM. kansasii subtype I has
several unique features in comparison to the established subtypes
II-V, consistent with its pathogenicity characteristics. We also
provide evidence that the espACD operon plays an important
role in acquiring virulence, at least in M. kansasii subtype II.
Our results support the notion that there are six subtypes of
M. kansasii, and the high levels of nucleotide variation amongst
the subtypes prompt us to propose that we should consider M.
kansasii subtypes I–VI as different species. Finally, we developed
a simple approach to distinguish M. kansasii subtypes I-V that
can be applied in clinical settings.
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